1.Study on Quality Standards for Shufeng Zhike Extract
Chinese Journal of Information on Traditional Chinese Medicine 2017;24(3):82-86
Objective To establish the quality standards for Shufeng Zhike Extract;To improve the controll ability of the extract and ensure medicine efficacy. Methods To establish a HPLC method for simultaneous differentiation of Paeoniae Radix Alba, Saposhnikoviae Radix, Polygoni Cuspidati Rhizomaet Radix, Glycyrrhizae Radix et Rhizoma, Belamcandae Rhizoma and Bupleurum in Shufeng Zhike Extract. Phenomenex Kintex C18 column (4.6 mm×100 mm, 2.6 μm) was used. Acetonitrile-0.05%phosphoric acid was as the mobile phase in gradient elution (0–25 min, 10%acetonitrile; 25–26 min, 10%→14% acetonitrile; 26–35 min, 14% acetonitrile; 35–36 min, 14%→34% acetonitrile;36–55 min, 34%acetonitrile) at flow rate of 0.8 mL/min, and column temperature was 40 ℃. The detection wavelength was 250 nm. To establish a HPLC method for simultaneous determination of Paeoniflorin and Prim-O-glucosylcimifugin in Shufeng Zhike Extract, Phenomenex Luna C18 column (4.6 mm×150 mm, 5 μm) was used; acetonitrile-0.05%phosphoric acid (12:88) was as the mobile phase at flow rate of 1 mL/min; column temperature was 40 ℃; the detection wavelength was 250 nm. Results The chromatographic peak separation with HPLC method for simultaneous differentiate of Paeoniae Radix Alba, Saposhnikoviae Radix, Polygoni Cuspidati Rhizoma et Radix, Glycyrrhizae Radix et Rhizoma, Belamcandae Rhizoma and Bupleurumin in Shufeng Zhike Extract was clear and negative control had no interference. The linear range of Paeoniflorin was 0.035 93–2.514 8 μg (r=0.999 5), and the average recovery was 100.54%(n=6). The linear range of Prim-O-glucosylcimifugin was 0.006 7–0.67 μg (r=0.999 5), and the average recovery was 100.39%(n=6). Conclusion The established quality standards are simple, reliable, and accurate. It can rapidly identificate Paeoniae Radix Alba, Saposhnikoviae Radix, Polygoni Cuspidati Rhizomaet Radix, Glycyrrhizae Radix et Rhizoma, Belamcandae Rhizoma and Bupleurum, and suitable for rapid determination of Paeoniflorin and Prim-O-glucosylcimifugin, which can provide the basis for the quality inspection of Shufeng Zhike Extract.
3. Influence of chronic kidney disease on prognosis of coronary artery disease
Academic Journal of Second Military Medical University 2006;27(10):1114-1117
Objective: To investigate the influence of chronic kidney disease (CKD), including slight renal damages, on prognosis of coronary artery disease (CAD). Methods: A retrospective study was performed in 732 patients who visited our Cardiology Department and Cardiothoracic Surgery Department in 2000-2004. All patients suspected of CAD underwent a selective coronary angiography. Five hundred and seventy-nine patients with established diagnosis of CAD were followed up and their cardiovascular events (angina pectoris, myocardial infarction, recurrent myocardial infarction, heart failure, stroke, death, etc.) were recorded. Patients with CAD were divided into normal, slight, moderate, and severe groups according to the degree of renal function damages. The influences of different degrees of renal damages on the prognosis of CAD were compared. Results: There were obvious differences in the morbidities of angina pectoris, myocardial infarction, recurrent myocardial infarction, heart failure, stroke, etc. in CAD patients with different degrees of renal function damages. The worse the renal function, the higher the incidences of angina pectoris, myocardial infarction, recurrent myocardial infarction, heart failure and stroke, etc (P<0.05). Conclusion: The severity of chronic renal insufficiency is positively correlated to the risks of CAD. The worse the renal function, the higher the incidence of cardiovascular events and the worse of CAD prognosis.
4.The therapeutic effects of intermittent hypoxia therapy in isolated systolic hypertension patients
Ling-Guang WU ; Jiao-Jie LI ; Guang LI ; Meng HU ;
Chinese Journal of Physical Medicine and Rehabilitation 2003;0(10):-
Objective To study the therapeutic effects of intermittent hypoxia therapy(IHT)in isolated systolic hypertension(ISH)patients with elevated cerebral blood flow velocity(Vp),and to explore the mechanisms involved.Methods Seventy-six ISH patients with increasing Vp and normal pulsatility index(PI)of the middle ce- rebral artery(MCA)were randomly divided into a therapy group and a control group.IHT was administrated in the therapy group,and air in the control group.The Vp and PI of the MCA and blood pressure(BP)were observed be- fore and after treatment.Results Vp and systolic blood pressure(SBP)were significantly reduced after IHT(P<0.01)compared with the therapy group's scores betore treatment,but PI and diastolic blood pressure showed no sig- nificant difference.There was no significant change in BP,Vp or PI in the control group before or after treatment. Conclusion IHT has therapeutic effects on ISH by reducing Vp and moderating SBP.
6.Phthalates esters and child health.
Chinese Journal of Contemporary Pediatrics 2009;11(11):949-953
Air Pollutants
;
analysis
;
Animals
;
Child
;
Esters
;
toxicity
;
Humans
;
Liver
;
drug effects
;
Phthalic Acids
;
analysis
;
metabolism
;
toxicity
;
Reproduction
;
drug effects
;
Soil Pollutants
;
analysis
;
Thyroid Gland
;
drug effects
;
Water Pollutants, Chemical
;
analysis
8.Study on Quality Standard for Lianqiaobaidu Pills
Lin WU ; Guang YANG ; Fei HUANG
Chinese Journal of Information on Traditional Chinese Medicine 2014;(5):95-97
Objective To imporve the quality standard of Lianqiaobaidu Pills. Methods The TLC method was established for ephedrae herba, sophorae flavescentis radix, paeoniae radix rubra, and RP-HPLC methed was established for the determination of chlorogenic acid in Lianqiaobaidu Pills. Zorbax SB-C18 (4.6 mm×150 mm, 5 μm) column was used with methanol-acetonitrile (2∶1) - 0.04% phosphoric acid (10∶90) as the mobile phase at flow rate of 0.8 mL/min. The detection wavelength was 326 nm. Results TLC chromatographic spots were clear, and negative control had no interference. The linear range of chlorogenic acid was 0.042 2-0.464 2 μg (r=1), the average recovery (n=6) was 98.96%. Conclusion The method is simple, reliable, with strong exclusive feature, and suitable for quality control of Lianqiaobaidu Pills.
9.Clinical Analysis of 30 Cases of Hypophosphatemic Rickets
ling-ling, WANG ; guang-chi, WU
Journal of Applied Clinical Pediatrics 2006;0(14):-
Objective To explore the causes,clinical characteristics and new measurements concerning with diagnosis and treatment of hypophosphatemic rickets.Methods Thirty children with hypophosphatemic rickets had been diagnosed and treated in our hospital from 1996 to 2005.Clinical data were retrospectively analyzed,including family history(the attack rates of parents and styles of inheritances),clinial characteristics(the attack ages and severity of skeletal developing malformation),serum biochemistry(plasma calcium,phosphate and alkaline phosphatase level),and X-ray in bones and treatment methods.Results All these patients presented with typical manifestations and signs of rickets.The minimum age of definitive diagnosis of hypophosphatemic rickets was 1.5 years old;the maximal age was 10 years old.All of 30 cases had failed to conventional treatment of vitamin D(VitD) deficient rickets for 6 months.Early supply of phosphate,VitD and calcium could effectively improve the outcomes of patients.Patients diagnosed and treated before 2 years old had better prognosis,while that diagnosed and treated later than 5 years old would be result in severe skeletal malformation.Conclusions It is difficult to distinguish hypophosphatemic rickets from VitD deficient rickets.It is very important that misdiagnosis of this disease usually leads to severe skeletal malformation.Early diagnosis and treatment can effectively improve the skeletal development of patients.
10.Clinical study of late-course hyperfractionated radiotherapy in the treatment of local advanced non-small cell lung cancer
Jing CHENG ; Guang WU ; Qin LI
China Oncology 2001;0(03):-
Purpose:To evaluate the clinical effect of late-course hyperfractionated (LCH) radiotherapy and conventionally fractionated (CF) radiotherapy for local advanced non-small cell lung cancer (NSCLC). Methods:From August 1995 to April 1998, 74 patients with inoperable stage Ⅲ NSCLC were randomized into two groups: CF and LCH. 37 patients in CF group received a fraction of 2 Gy daily, 5 days per week, to the total dose of 65~70 Gy /6.5~7 weeks. 37 patients in LCH group were treated with the same fractionation as CF group to the dose of 40 Gy, and then followed by LCH radiotherapy: 1.2Gy, twice daily, with the interval of 6 hours between fractions, to the total dose of 64 Gy/6 weeks. Results:The overall response rate in LCH group and CF group were 78.4%(29/37) and 62.2%(23/37) respectively, the difference was significant (P